{"data":{"id":3004,"citation":"Chorvat RJ, Berbaum J, Seriacki K, McElroy JF.: JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities. Bioorg Med Chem Lett, Volume 22 (19), 2012","title":"JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities.","doi":"10.1016\/j.bmcl.2012.08.004","doi_url":"https:\/\/doi.org\/10.1016\/j.bmcl.2012.08.004","pmid":"22959249","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/22959249\/","year":2012,"journal":"Bioorg Med Chem Lett","volume":"22","issue":"19","page":"6173-6180","authors":[{"first_name":"Berbaum J","last_name":null,"full_name":null},{"first_name":"Chorvat RJ","last_name":null,"full_name":null},{"first_name":"McElroy JF.","last_name":null,"full_name":null},{"first_name":"Seriacki K","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3004","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3004","created_at":"2024-05-21T09:15:32.000000Z","updated_at":null}}